Investment Team

  • Michael Dial, PhD

    Principal

    Michael Dial, PhD

    Prior to joining Hatteras, Mike was a Vice President in Silicon Valley Bank’s Corporate Finance Group where he focused on emerging life science companies and venture capital funds. Prior to SVB, he held research scientist positions in the Department of Biochemistry at UNC-Chapel Hill, the Laboratory of Structural Biology at the National Institute of Environmental Health Sciences, and the UNC-Duke Michael Hooker Proteomics Center. He has performed research in the fields of cell cycle regulation, proteomics, and cancer therapy. Mike has published seven peer reviewed scientific articles and has presented at numerous international scientific conferences.

    Mike serves on the board of Curoverse and is a board observer at Viamet Pharmaceuticals, Clinverse, and G1 Therapeutics. He holds a doctorate in biochemistry and biophysics from the University of North Carolina at Chapel Hill.

    Community and Board Engagements:

    Mike has served on various committees and panels for the North Carolina Biotech Center, Council for Entrepreneurial Development, SE BIO, PTP NEXT and Durham’s Partnership for Children.

  • Jeff Terrell

    Associate

    Jeff Terrell

    Prior to joining the Hatteras team in 2012, Jeff worked in a sales and clinical support role for Medtronic, a large medical device company. Based in Georgia and South Carolina, Jeff worked in the operating room with neurosurgeons and orthopedic surgeons, selling and providing service on image-guided surgery equipment and spinal implants. Prior to working with Medtronic, Jeff devoted two years to pursuing a career as a professional quarterback, spending time with the Kansas City Chiefs and Dallas Cowboys. Since joining Hatteras, Jeff has worked in a corporate development role in a medical device portfolio company, and assisted in overall firm operations, deal flow activities and diligence.

    Jeff is a board observer at Medfusion, NeuroTronik, GrayBug, ORIG3N, Contego Medical, Wildflower Health and Medikidz. He holds a bachelor’s degree from Princeton University, and an MBA from Duke University, with a focus on healthcare and finance.

    Community and Board Engagements:

    Jeff serves on the Board of Directors of the Council for Entrepreneurial Development in Durham, and has served on various panels for the North Carolina Biotech Center and SE BIO.

  • Ben Scruggs, PhD

    Analyst

    Ben Scruggs

    Prior to joining Hatteras in 2016, Ben completed at a postdoctoral fellowship in the Epigenetics and Stem Cell Biology Laboratory at the National Institute of Environmental Health Sciences. He has performed research in the fields of genomics, metabolism, RNA biology, and transcription regulation. His research has been published in peer-reviewed journals including Molecular Cell and Cell Metabolism, among others. Ben focuses on the firm’s deal flow process and due diligence.

    Ben is a board observer at Trefoil Therapeutics. He received his B.E. in biomedical engineering from Vanderbilt University and a Ph.D. in molecular cell biology from Washington University in St. Louis.

    Community and Board Engagements:

    Ben has served on various committees and panels for the Council for Entrepreneurial Development, SE BIO, NHLBI and SC BIO.